146 related articles for article (PubMed ID: 11215403)
1. [Evolution and update of detoxification techniques for opiate addicts].
Yui K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct; 20(4):175-7. PubMed ID: 11215403
[No Abstract] [Full Text] [Related]
2. Opioid dependence.
Praveen KT; Law F; O'Shea J; Melichar J
Am Fam Physician; 2012 Sep; 86(6):565-6. PubMed ID: 23062049
[No Abstract] [Full Text] [Related]
3. Antagonist treatment of opioid withdrawal translational low dose approach.
Mannelli P; Gottheil E; Van Bockstaele EJ
J Addict Dis; 2006; 25(2):1-8. PubMed ID: 16785213
[TBL] [Abstract][Full Text] [Related]
4. Promise of extended-release naltrexone is a red herring.
Bart G
Lancet; 2011 Aug; 378(9792):663; author reply 663-4. PubMed ID: 21856474
[No Abstract] [Full Text] [Related]
5. Commercial factors override science in combination addiction drug trial.
Byrne A
Clin Pharmacol Ther; 2011 Nov; 90(5):649; author reply 650. PubMed ID: 21956617
[No Abstract] [Full Text] [Related]
6. Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification.
Buntwal N; Bearn J; Gossop M; Strang J
Drug Alcohol Depend; 2000 May; 59(2):183-8. PubMed ID: 10891632
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine versus methadone use in opiate detoxification, are there other factors that should be considered?
Bhupal HK
Br J Gen Pract; 2012 Feb; 62(595):68-9. PubMed ID: 22520768
[No Abstract] [Full Text] [Related]
8. The pharmacological treatment of opioid addiction--a clinical perspective.
Lobmaier P; Gossop M; Waal H; Bramness J
Eur J Clin Pharmacol; 2010 Jun; 66(6):537-45. PubMed ID: 20169438
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine.
Harris DS; Jones RT; Welm S; Upton RA; Lin E; Mendelson J
Drug Alcohol Depend; 2000 Dec; 61(1):85-94. PubMed ID: 11064186
[TBL] [Abstract][Full Text] [Related]
10. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
[TBL] [Abstract][Full Text] [Related]
11. Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance.
Stine SM; Kosten TR
Am J Drug Alcohol Abuse; 1994 Nov; 20(4):445-58. PubMed ID: 7832179
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine and methadone: a comparison of patient completion rates during inpatient detoxification.
Blondell RD; Smith SJ; Servoss TJ; DeVaul SK; Simons RL
J Addict Dis; 2007; 26(2):3-11. PubMed ID: 17594993
[TBL] [Abstract][Full Text] [Related]
13. Clinical treatment of opioid addiction and dependence.
Ling W; Rawson RA; Compton M
Methods Mol Med; 2003; 84():285-95. PubMed ID: 12703332
[No Abstract] [Full Text] [Related]
14. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
[TBL] [Abstract][Full Text] [Related]
15. Transfer from high dose methadone to buprenorphine/naloxone.
Wallace M
Aust Nurs J; 2011 Jul; 19(1):42-3. PubMed ID: 21853690
[No Abstract] [Full Text] [Related]
16. Buprenorphine and naloxone interactions in methadone maintenance patients.
Mendelson J; Jones RT; Welm S; Brown J; Batki SL
Biol Psychiatry; 1997 Jun; 41(11):1095-101. PubMed ID: 9146820
[TBL] [Abstract][Full Text] [Related]
17. Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone.
Kelty E; Hulse G
Int J Drug Policy; 2017 Aug; 46():54-60. PubMed ID: 28609749
[TBL] [Abstract][Full Text] [Related]
18. Injectable extended-release naltrexone for opioid dependence.
Woody GE; Metzger DS
Lancet; 2011 Aug; 378(9792):664-5; author reply 666. PubMed ID: 21856476
[No Abstract] [Full Text] [Related]
19. A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls.
Kelty E; Hulse G
Drugs; 2017 Jul; 77(11):1199-1210. PubMed ID: 28536980
[TBL] [Abstract][Full Text] [Related]
20. Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.
Seifert J; Metzner C; Paetzold W; Borsutzky M; Ohlmeier M; Passie T; Hauser U; Becker H; Wiese B; Emrich H; Schneider U
Addict Biol; 2005 Jun; 10(2):157-64. PubMed ID: 16191668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
